跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,525 条关于
“tumor mutation burden”
全部
38,525
临床试验
26,032
药物
607
机构
101
资讯
11,785
2年前
GigaPath AI Model Shows Superior Accuracy in Predicting Cancer Mutations and Tumor Burden
去年
Marengo's Invikafusp Alfa Shows Promise in Anti-PD-1 Resistant Cancers
去年
Study Reveals TMB Levels Impact Immunotherapy Outcomes in Breast Cancer Treatment
去年
Marengo Therapeutics Advances Invikafusp Alfa into Phase 2 for PD-1 Resistant Tumors, Expands Trial to Europe
去年
Marengo's Invikafusp Alfa Shows Promise in Anti-PD-1 Resistant Solid Tumors
去年
Radiation Therapy Overcomes Primary Resistance to Pembrolizumab in Immunologically Cold NSCLC
6个月前
Long-Term Follow-Up Data Confirm Sustained Survival Benefits of PD-1 Inhibitors in Nasopharyngeal and Esophageal Cancers
去年
Dostarlimab Shows Promise in Neoadjuvant Treatment of dMMR Colorectal Cancer: ASCO 2024 Update
去年
Immunotherapy in NSCLC: Experts Address Patient Selection and Access Challenges
去年
Geneseeq Secures FDA 510(k) Clearance for Comprehensive 425-Gene Tumor Profiling Assay
第 1 页,共 1179 页
上一页
下一页